基于空间计量的生物医药产业集聚影响因素研究  

Study on Influential Factors of Biopharmaceutical Industry Agglomeration Based on Spatial Econometric Analysis

作　　者：席晓宇[1] 朱玄[1] 褚淑贞[1] 

机构地区：[1]中国药科大学医药产业发展研究中心,南京211198

出　　处：《中国药房》2015年第1期5-8,共4页China Pharmacy

基　　金：江苏省教育厅高校哲学社会科学研究项目(No.2013SJD790062);中国药科大学医药产业发展研究中心研究基金重点资助项目(No.CPUSJ1305)

摘　　要：目的:探究我国生物医药产业集聚的空间影响因素,并提出发展我国生物医药产业集聚的建设性建议。方法:基于新经济地理学和空间计量经济学理论,建立生物医药产业集聚影响因素的空间计量模型,全面分析空间各因素对我国生物医药产业集聚的作用。结果与结论:我国生物医药产业存在较明显的空间集聚性和空间正相关性。空间计量模型表明,生物医药产业企业数、从业人员数、城镇居民人均医疗保健支出、科技经费中政府资金比例及金融机构贷款额每提高1%,生物医药产业集聚水平相应地提高0.897%、6.617%、2.36%、2.48%和6.44%,表明产业差异、人力资本水平、市场消费需求、政府支持程度和金融发展水平对其集聚程度影响显著。因此,应当加强政府科学引导,充分利用人力资源,并构建各医药产业集聚区的联动机制。OBJECTIVE： To investigate the influential factors of biopharmaceutical agglomeration in China, and to put forward constructive suggestion for the development of biopharmaceutical industry agglomeration in China. METHODS： The spatial econo metric model was established for influential factor of biopharmaceutical industry agglomeration, based on economic geography and spatial econometric theory. The effects of each spatial factor on biopharmaceutical industry agglomeration were analyzed completely. RESULTS ＆ CONCLUSIONS： Biopharrnaceutical industry has obvious spatial agglomeration and positive correlation. When the number of biopharmaceutical enterprises and employed staff, urban per capita health care spending, ratio of government funds in S＆T fund, loan amount of financial institutions increase 1% respectively, the agglomeration levels increase by 0.897%, 6.617%, 2.36%, 2.48% and 6.44%, respectively. It illustrates industrial difference, human capital, market cosumption demand, govern ment support and financial development influence agglomeration significantly. As a consequence, it is needed to enhance govern ment scientific guide, make full use of human resource and create the linkage mechanism within pharmaceutical industry agglomera tion areas.

关 键 词：生物医药 产业集聚 空间计量经济学 

分 类 号：R956[医药卫生—药学]